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Summary
How cells communicate during development and regenera-
tion is a critical question. One mechanism of intercellular
communication is via exosomes, extracellular vesicles that
originate by the fusion of multivesicular endosomes with
the plasma membrane [1–8]. To model exosome-based
intercellular communication, we used Madin-Darby canine
kidney (MDCK) cell cysts grown in 3D gels of extracellular
matrix, which form tubules in response to hepatocyte growth
factor (HGF). We report that GPRC5B, an orphan G protein
coupled receptor, is in exosomes produced by HGF-treated
cysts and released into the cyst lumen. Exosomal GPRC5B
is taken up by nearby cells and together with HGF promotes
extracellular signal-regulated kinase 1/2 (ERK1/2) activation
and tubulogenesis, even under conditions where tubulogen-
esis would otherwise not occur. Recovery from injury, such
as acute kidney injury (AKI), often recapitulates develop-
mental processes. Here, we show that GPRC5B is elevated
in urinary exosomes from patients with AKI. Our results
elucidate how GPRC5B is carried by exosomes and aug-
ments HGF-induced morphogenesis. The unexpected role
of exosomes in transporting GPRC5B between cells during
morphogenesis and the ability of GPRC5B to predict the dis-
ease state of AKI elucidate a novel mechanism for intercel-
lular communication during development and repair.
Results and Discussion
As a model system to study mammalian organogenesis, we
grow Madin-Darby canine kidney (MDCK) cells in 3D organo-
typic culture in thick gels of extracellular matrix (ECM) so
that the cells form cysts with a central lumen lined by a mono-
layer of polarized epithelial cells. When stimulated with HGF,
these cells proliferate and undergo tubulogenesis, which is
reminiscent of tubulogenesis found in several developmental
processes. We previously identified genes that are regulated
during hepatocyte growth factor (HGF)-induced tubulogenesis
[9]. We focused now on GPRC5B, which is highly upregulated
early in in vitro tubulogenesis and is particularly highly
expressed in the ureteric bud during embryonic kidney devel-
opment [10]. GPRC5B is a poorly characterized G protein
coupled receptor, which was originally cloned as a reti-
noic-acid-induced gene (also called RAIG-2) [11]. It has
been implicated in neuronal cell fate determination [12] and*Correspondence: keith.mostov@ucsf.eduobesity-associated inflammation [13]. However, its molecular
signaling mechanisms and the identity of any potential ligand
activator or interacting partners, with the exception of the
Fyn kinase, remain largely unknown. We noticed that w9%
of the genes that we previously identified as undergoing
temporal regulation during in vitro tubulogenesis, including
GPRC5B, are present in urinary exosomes (data not shown)
when compared with exosome databases [14, 15], suggesting
a potential role for exosomes in tubulogenesis. We first
confirmed by quantitative PCR that GPRC5B was induced in
MDCK cells that have been exposed to conditioned medium
from MRC5 cells, a fibroblast cell line providing tubulogenic
factors, including HGF (Figure 1A). HGF alone can cause tubu-
logenesis, although not as well as MRC5 conditioned medium,
and we found that HGF alone was also sufficient for GPRC5B
induction.
Induction of GPRC5B was blocked by U0126, a MEK
inhibitor, indicating the induction is downstream of the MAP
kinase pathway, a key signaling pathway in tubulogenesis
[16] (Figure 1A). Next, we tested whether GPRC5B induction
is required for tubulogenesis inMDCK cysts grown in collagen.
Two functional small hairpin RNAs (shRNAs) targeting
GPRC5B significantly decreased the fraction of cysts making
tubules upon HGF treatment, compared to control cells
expressing an irrelevant shRNA (Figures 1B and 1C). Addi-
tionally, the average length of the tubules that did form was
significantly shorter in shRNA-mediated knockdown cells (Fig-
ure 1D; Figure S1A available online), suggesting that GPRC5B
controls both the number and length of tubules.
Because GPRC5B is required for tubulogenesis, we tested
whether exogenous expression of GPRC5B fused to green
fluorescent protein (GPRC5B-GFP) could confer outward
growth to MDCK cells grown in Matrigel, in which (unlike
collagen I gels) wild-type (WT) MDCK cysts are unable to
invade in response to HGF [17]. This provides a more stringent
model to examine cell movement and tubulogenesis. Unex-
pectedly, cysts expressing GPRC5B-GFP invaded Matrigel
as tubules or scattered cells upon HGF treatment (referred to
here as outward growth), while control cysts expressing GFP
alone showed virtually no outward growth into the surrounding
Matrigel. Instead, cells accumulated in the lumen, indicating
the lack of outward growth is not due to the absence of HGF
signaling (Figure 1E). We further examined cysts that ex-
pressed GPRC5B-GFP at various subthreshold levels and
found that, in response to HGF, high expression resulted in
outward growth, while low expression resulted in accumula-
tion of cells in the lumen (Figure S1B), suggesting that the
expression level of GPRC5B determines outward growth.
Indeed, when cells were sorted on the basis of GFP fluores-
cence using fluorescence-activated cell sorting, cysts formed
from cells with the highest 10% of expression level of
GPRC5B-GFP had significantly more outward growth in
response to HGF, compared with those from the lowest 10%
(Figure 1F). Finally, shRNA directed against GPRC5B also
decreased outward growth induced by GPRC5B-GFP (Fig-
ure 1G). The observed outgrowth is specific for GPRC5B,
because overexpression of CD82, an irrelevant exosome pro-
tein [18], did not exert a similar effect (Figure S1C). These data
Figure 1. HGF-Induced GPRC5B Contributes to
Outward Growth in ECM Microenvironments
(A) GPRC5B expression of MDCK cells treated
with conditioned (cond.) medium from MRC5,
12.5 ng/ml HGF, or 12.5 ng/ml HGF + 10 mM
U0126 for 24 hr. Values are the mean 6 SE of
three independent experiments.
(B) Knockdown efficiency of lentiviral shRNAs
targeting GPRC5B in MDCK cysts. The control
with scrambled shRNA (SCR KD) is normalized
to 100%. GPRC5B expression (A and B) was
determined by quantitative RT-PCR. Values
are the mean 6 SE of three independent
experiments.
(C) Quantification of in vitro tubule formation in
collagen I. Fraction of tubule formation was
calculated from tubules counted upon HGF stim-
ulation and normalized to control knockdown
(SCR). Values are the mean 6 SE of three inde-
pendent experiments.
(D) Quantification of tubule length, the length
from cyst wall to the leading edge of growing
tubule. Data are presented as whisker-Tukey
plots, where boxes encompass values between
the 25th and 75th percentiles, centered lines represent median values, and whiskers span minimum to maximum values.
(E) Representative images of outward growth of cysts inMatrigel upon HGF treatment. GPRC5B-GFP allows cysts to invade as tubules (filled arrowheads) or
scattered cells (asterisk), while GFP causes cells to accumulate in the lumen (open arrowheads). These effects were seen at both 48 and 78 hr. The insets
show higher magnifications of the regions indicated. Scale bars represent 100 mm (insets, 50 mm).
(F and G) Quantification of outward growth in cysts expressing higher versus lower level of GPRC5B-GFP via overexpression (F) and shRNA-mediated
knockdown (G). The transcript level of GPRC5B in cells with bottom 10% intensity shows 3.38- 6 0.424-fold increase when compared with that of endog-
enous GPRC5B from cells stimulated with 12.5 ng/ml HGF. Values are the mean 6 SE of three independent experiments.
Significance was calculated using a Student’s t test and labeled as *p < 0.05, **p < 0.001, and ***p < 0.0001 in figures. See also Figure S1.
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growth of cysts.
We found GPRC5B-GFP is localized at the apical membrane
and/or in the intraluminal space of cysts (Figure 2A), suggest-
ing that GPRC5B may be exported through extracellular
vesicles from the apical surface. Differential centrifugation of
conditioned medium in contact with the apical surface of
monolayer-grown MDCK cells was performed to fractionate
extracellular vesicles into fractions enriched in microvesicles
(released by blebbing of the plasma membrane) or exosomes
(released by fusion of multivesicular endosomes with the
plasma membrane) (Figure 2B). Electron micrographs
confirmed that each fraction contained a majority of vesicles
that are consistent with the known diameters of microvesicles
(111.5 6 45.6 nm) and exosomes (63.0 6 19.4 nm) [19, 20].
Marker analysis with phosphohistone and cytochrome c
showed that the exosome fraction was not contaminated
with apoptotic bodies. Hsp70, a known exosome marker in
MDCK, was present in the exosome fraction (not shown).
Thus, released GPRC5B-GFP was primarily on exosomes.
The releaseof exosomes inother systemshasbeenshown to
dependon the small GTPasesRab7, Rab11,Rab27, andRab35
[21–24]. We tested whether these colocalize with GPRC5B-
GFP. Rab35 had the highest colocalization with GPRC5B-
GFP (Figure S2), though the possibility of involvement of the
other Rabs remains. We grew MDCK cells as a monolayer
and tested the effect on release of GPRC5B-GFP in exosomes
of constitutively active (QL), dominant-negative (SN), and wild-
type (WT) alleles of Rab35 fused to the fluorescent protein
mCherry (Figure 2C). In contrast to Rab35-WT and Rab35-QL,
expression of Rab35-SN decreased release of GPRC5B-GFP.
These data suggest GPRC5B is apically released in exosomes
via intracellular trafficking controlled by Rab35.
The cis-acting signals that direct proteins into exosomes
are poorly understood [25]. We used a series of truncationmutations in GPRC5B-GFP, to determine the signal within
GPRC5B that directs the protein into exosomes (Figure S3A,
left). Removal of the entire 101-amino-acid (aa) cytoplasmic,
C-terminal tail (D101) spanning residues 286–384, abolished
exosomal release of GPRC5B-GFP. This is unlikely due tomis-
folding, as D101 reached the cell surface. In sharp contrast,
removal of the C-terminal 80 aa did not block exosomal
release. Using alanine scanning, a triple alanine mutant, 286–
288A, showed impairment of release of GPRC5B-GFP compa-
rable to D101, without loss of surface expression (Figure 3A;
Figure S3A). In addition, 286–288A accumulated in small vesi-
cles, possibly endosomes, which were much more prominent
compared with WT GPRC5B-GFP (Figure 3B). The correlation
of reduction in exosomal release with intracellular vesicular
accumulation suggests potential interference in endosome
traffic.
We next analyzed budding of GPRC5B-GFP into endo-
somes. Because GPCRs often use ubiquitination of cyto-
plasmic-exposed lysines for intraendosomal transport [26],
we mutated all such lysines in GPRC5B-GFP to arginine
(iKRs), which had reduced exosomal release compared to
WT GPRC5B-GFP (Figure 3A; Figure S3B). To improve visual-
ization of the location of GPRC5B-GFP, we enlarged endo-
somes by overexpressing constitutively active Rab5(QL) [27]
(Figure 3C; Figure S2). WT GPRC5B-GFP was diffusely distrib-
uted throughout the lumen of enlarged endosomes, presum-
ably on intraluminal vesicles that are below resolution of the
microscope. In contrast, iKRs and 286–288A often appeared
as aggregates on the limiting membrane, rather than diffuse
in the lumen (Figure 3C). 286–288A was often in a single aggre-
gate on the membrane. Quantitation showed a significant
reduction of 286–288A in the lumen and redistribution to the
limiting membrane (Figure 3D). These data suggest that the
cytoplasmic lysines and juxtamembrane residues 286–288
determine transport of GPRC5B into the lumen of the
Figure 2. GPRC5B Is Apically Released on
Exosomes through a Rab35-Dependent Pathway
(A) Luminal localization of GPRC5B-GFP. Cysts
expressing GPRC5B-GFP (green) were immuno-
stained with Hoechst 33342 (nuclei, blue) and
ZO-1 (tight junction, white). The scale bar repre-
sents 20 mm.
(B) Immunoblots showing indicated proteins
in total lysates and microvesicle and exosome
fractions from cells expressing GFP or GPRC5B-
GFP. Asterisk indicates glycosylated GPRC5B-
GFP, as determined by deglycosylation reactions
with PNGases F, O-Glycosidase, Neuraminidase,
N-acetylglucosaminidase, and Neuraminidase
(data not shown). Representative transmission
electronmicrographs of fractionated extracellular
vesicles are shown below. Vesicles <100 nm
are enriched in the exosome fraction, while
vesicles >100 nm are enriched in the microvesicle
fraction. Scale bars represent 100 nm.
(C) Representative immunoblots and quantifica-
tion showing GPRC5B-GFP in total lysates and
exosomes from the tissue culture supernatants
of stable cell lines doubly transfected with
indicated constructs. To minimize toxicity
associated with overexpression of Rab35, a minimal cytomegalovirus promoter was used to drive the expression of mCherry-Rab35 WT, QL
(constitutively active), or SN (dominant negative). Values are the mean 6 SE of four independent experiments.
See also Figure S2.
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of the endosome, thereby leading to its eventual exosomal
release. Finally, cysts expressing 286–288A exhibited signifi-
cantly decreased outward growth (Figure 4A), providing a
direct link between endosomal release of GPRC5B and its bio-
logical function.
Though little is known about how exosomes are transferred
to target cells [28, 29], several membrane-anchored ligands
involved in development, such as amphiregulin and Wnt pro-
teins, have been shown to be released in exosomes and act
on target cells [3, 8]. Receptor tyrosine kinase c-Met is released
from melanoma cells via exosomes and causes bone marrow
cells to have an increased level of c-Met [6], though physical
transfer of c-Met between these cell types has not been shown.
We therefore tested whether an exosomally released receptor,
GPRC5B-GFP, is taken up by other cells and promotes out-
ward growth.Wegeneratedmosaic cystswith twopopulations
of MDCK cells: target cells expressed cytoplasmic red fluores-
cenceprotein (RFP)butwereotherwiseWT, anddonor cells ex-
pressed GPRC5B-GFP. Confocal microscopy confirmed that
when grown in mosaic cysts, GPRC5B-GFP was observed at
the apical membranes of both cell types (Figure S4A) and in
the interior of the RFP-expressing cells that were not in contact
with cells producing GPRC5B-GFP (Figure 4B). Furthermore
when exosomes purified from conditionedmedium of cells ex-
pressing GPRC5B-GFP were added to the exterior of cysts
comprised of WT MDCK, the GPRC5B-GFP was internalized
into the WT MDCK (Figure S4B). A similar process of uptake
from the basolateral surfacemay occurwhenpolarity is disrup-
ted due to wounding, HGF stimulation, or cancer [30].
Next, we askedwhether exogenously added exosomes from
cells expressing GPRC5B-GFP could induce outward growth
in WT MDCK cysts grown in Matrigel (Figure 4C). Upon HGF
treatment, cysts underwent outward growth when exosomes
purified from cells expressing GPRC5B-GFPwas added, while
exosomes from cells expressing only GFP, or exosome-
depleted medium from cells expressing GPRC5B-GFP, did
not cause outward growth.The MAP kinase pathway is downstream of c-Met and is
essential for tubulogenesis [16, 31]. We tested whether
GPRC5B-GFP modulates the MAP kinase pathway as deter-
mined by phosphorylation status of ERK1/2 in lysates from
cysts. Upon HGF stimulation, ERK1/2 activation was elevated
in cysts expressing GPRC5B-GFP, compared with cysts
expressing GFP alone (Figure 4D). We next tested whether
transfer of exosomes containing GPRC5B-GFP was respon-
sible for the increased ERK1/2 activation.We grewMDCK cells
expressing either GFP or GPRC5B-GFP as monolayers and
collected the conditioned medium. Exosomes were purified
from this by centrifugation, resuspended in culture medium,
and added to WT MDCK cysts, which were assayed for
ERK1/2 activation. (As an additional control, resuspended
exosomes from the GPRC5B-GFP conditioned medium were
recentrifuged to give an ‘‘exosome depleted’’ condition.)
Exosomes containing GPRC5B-GFP potentiated ERK1/2
activation in recipient cysts ofWTMDCK cells (Figure 4E), sug-
gesting that GPRC5B augments ERK1/2 activation in recipient
cells through exosomal transfer. In the light of our findings, we
propose that induced GPRC5B potentiates MAP kinase acti-
vation in HGF- stimulated cells. Hyperactivation of MAP kinase
signaling leads to cell scattering rather than tubulogenesis.
Exosomal release of GPRC5B likely acts to (1) downregulate
and avoid inappropriate overactivation of ERK1/2 in exosome
releasing cells and (2) laterally propagate ERK1/2 activation
in nearby exosome recipient cells. Thus, exosomes are pro-
posed to be part of a signaling mechanism that controls a
collective response to HGF for invasive growth.
Developmental processes, such as tubulogenesis, are often
recapitulated during wound repair and regeneration. Because
our data suggest that exosomes can carry a signal from donor
cells to recipient cells during tubulogenesis, we testedwhether
GPRC5B in exosomes fromMDCKcells stimulatedwithMRC5-
conditioned medium can increase collective cell migration in a
model ofwoundhealing. In this assay,MDCKcells aregrownas
amonolayer on a solid support. A silicone rubber barrier forms
a rectangular, cell-free gap, 5006 50 mmwide, in the middle of
Figure 3. The Juxtamembrane Residues at
the C-Terminal Tail Determine the Transfer of
GPRC5B from the Limiting Membrane to the
Lumen of Late Endosomes, Thereby Leading to
Its Exosomal Release
(A) Percentage distribution of GPRC5B-GFP in
total cell lysate and exosomes stably expressing
WT (wild-type), D101 (no C-terminal tail), iKRs
(arginine-to-lysine substitution of all intracellular
lysines), or 286–288A (alanine substitution in
residues 286–288). Values are the mean 6 SE of
three independent experiments.
(B) Representative GPRC5B-GFP localization of
cells expressing WT or 286–288A. A series of
z-axis confocal images captured as in scheme at
left. Arrowheads indicate intracellular accumula-
tion of 286–288A. The scale bar represents 20 mm.
(C) Representative GPRC5B-GFP localization
in endosomes from cells expressing WT, iKRs,
or 286–288A, together with mCherry-Rab5QL.
To better visualize GPRC5B-GFP distribution in
endosome lumens, inverted images are shown.
Arrowhead indicates an aggregate of 286–288A
on the endosome limiting membrane. The scale
bar represents 10 mm.
(D) Quantification of the distribution of GPRC5B-
GFP in enlarged endosomes. By measuring pixel
intensities over the luminal area of endosomes
marked with an asterisk, the distribution of
GPRC5B-GFP in endosome lumens was calcu-
lated as percent coefficient variation (CV). Data
are presented as whisker-Tukey plots, as used
in Figure 1D. See also Supplemental Information.
See also Figure S3.
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begin to migrate to fill in the cell-free region. This is similar to a
scratch wound assay, but more reproducible. The monolayer
showed markedly increased migration when incubated with
isolated exosomes from MDCK cells stimulated with MRC5-
conditioned medium (Figure 4F; Figure S4C). Importantly, this
enhanced migration was significantly decreased when exo-
somes were isolated fromMDCK cells expressing shRNAs tar-
getingGPRC5B, suggesting endogenousGPRC5B transferred
via exosomes stimulates migration.
Recovery from injury and regeneration often recapitulates
developmental processes, although the role of exosomes in
injury repair has been little explored. Such processes are
very important clinically. For instance, acute kidney injury
(AKI), where the epithelial cells lining the tubules of the kidney
are injured or die, is a major source of morbidity and mortality
in hospitalized patients, associated with upward of 10 billion
dollars in costs each year in the United States [32]. Further-
more, the consequences of incomplete recovery leading to
chronic kidney disease are a major clinical concern that has
only recently been appreciated [33, 34]. So far,methods to pre-
dict which patients will suffer long-term sequelae from AKI are
lacking. The involvement of exosome-mediated transfer of
GPRC5B in tubulogenesis and wound healing in culture led
us to examine whether this protein is involved in AKI. HGF
and c-Met play an important role in AKI. In AKI, both serum
HGF and renal c-Met expression are increased, and c-Met is
activated concomitantly [35–37]. Indeed, HGF enhances renal
repair in animal models of AKI [38, 39]. First, we asked where
GPRC5B was expressed in human kidney. Marker analysis
showed GPRC5B was present predominantly in collecting
ducts, to a much lesser extent in proximal tubules, and, rarely,
in the loop of Henle (Figure S4D). To determine the involvementof GPRC5B in AKI, we isolated exosomes from the urine of
patients who met predefined criteria for AKI [40]. Urine was
collected from critically ill human subjects who met inclusion
criteria for a prospective cohort study under a protocol that
was reviewed and approved by the University of California,
San Francisco Institutional Review Board. Immunoblotting
showed a significant increase of urinary GPRC5B in patients
with AKI at day 1 (Figure 4G). Collectively, these data suggest
urinary exosomal GPRC5B might potentially serve as a much-
needed biomarker for AKI.
Together, our study illuminates the surprising roles of exo-
somes and GPRC5B in development and regeneration and is
an important step in understanding and improving the limited
regenerative capacity of the kidney.
Experimental Procedures
Invasive Growth Assay in Extracellular Matrices
In vitro tubule formation assays were previously described [9]. Briefly, for
the HGF-induced tubule formation assay, 4-day-old cysts overlaid onMatri-
gel and grown in 2% Matrigel were simulated for 48 or 78 hr with 12.5 ng/ml
recombinant HGF, together with collagen I as supporting 3D matrix. For
outward growth in nonpermissive ECM microenvironment, 2% Matrigel
was used as supporting matrix when 4-day-old cysts were stimulated
with 12.5 ng/ml HGF. For counting tubule length, digital images were taken
from the center of culture chamber well with a DinoXcope microscope
(Dino-Lite). The distance between the leading edge of tubule and cyst wall
wasmarked with Freehand selection and was then measured using ImageJ.
Other methods are described in Supplemental Experimental Procedures.
Supplemental Information
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be foundwith this article online at http://dx.doi.org/
10.1016/j.cub.2013.12.010.
Figure 4. Intercellular Transfer of GPRC5B via
Exosomes Enhances HGF-Induced Morpho-
genesis
(A) Quantification of outward growth in cysts ex-
pressing GPRC5B-GFP WT, iKRs, or 286–288A.
Thepercentageof outwardgrowthwasmeasured
as described in Figure 1. Values are the mean 6
SE of three independent experiments.
(B) Representative confocal images showing a
mosaic cyst with MDCK cells expressing either
GPRC5B-GFP or red fluorescent protein (RFP).
In (iii), The GPRC5B-GFP expressing cell is out-
lined by a hand-drawn line. Box outlined in
black in (i) and (iv) marks an RFP-expressing
cell that is not in contact with cells expressing
GPRC5B-GFP, as determined by confocal
sectioning (not shown). (iv) and (v) are inverted
(black to white) to better visualize the GPRC5B-
GFP that is taken up by the RFP-expressing
target cells. Arrowheads in (iv) and (v) indicate
GPRC5B-GFP+ puncta taken up by RFP+ cells.
The scale bar represents 20 mm.
(C) Representative images and quantification
showing the effect of exosome transfer from cells
expressing GPRC5B-GFP. Four-day-old cysts
of WT MDCK cells in Matrigel were stimulated
with indicated serum-free (s.f.) medium or puri-
fied exosomes, together with 12.5 ng/ml HGF.
Values are the mean 6 SE of three independent
experiments.
(D) Representative immunoblots showing phos-
phorylated and total ERK1/2 in cysts stimulated
as in (C).
(E) Representative immunoblots showing
augmented ERK1/2 activation in cysts that
received exosomes from cells expressing GFP
or GPRC5B-GFP after HGF stimulation. Note
that exosome depletion (depl.) abolished ERK1/
2 potentiation observed in recipient cells stimu-
lated with HGF, together with exosome transfer
from cells expressing GPRC5B-GFP.
(F) Wound healing due to endogenous GRPC5B carried in exosomes. MRC5 cells were grown in serum-free medium and the resultant conditioned medium
was centrifuged to remove any exosomes. This MRC5 conditioned medium was then added to MDCK cells grown as monolayers and expressing either
shRNA for GPRC5B (GPRC5B KD) or a scrambled control (SCR KD). The conditioned medium from these MDCK cells was then subjected to centrifugation
to purify exosomes. The exosomes, either GPRC5B KD or SCR KD, were then added to a second set of cultures of WT MDCK cells grown as monolayers;
these cultures had an ibidi silicone barrier to prevent growth in a gap region. The silicone barrier was removed immediately before addition of the purified
exosomes. Migration was measured as the area of the gap that was covered by migrating cells over 6 hr. Values are the mean 6 SE of three independent
experiments.
(G) Quantification of GPRC5B in human urinary exosomes. Urine was collected at the first day after critically ill subjects met predefined criteria for AKI and
provided informed consent. Samples were processed as blinded samples to measure GPRC5B in exosomes using immunoblotting.
See also Figure S4.
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